Smisson-Cartledge
Country not established
- Devices
- 1
What Smisson-Cartledge makes
Smisson-Cartledge manufactures the Smisson Stabilization System, a medical device designed for spinal stabilization procedures. This product is intended for use in orthopedic surgeries to provide structural support to the spine, aiding in the stabilization of vertebrae during healing or surgical interventions.
The company’s portfolio is regulated under Class II devices in the United States, with the Smisson Stabilization System authorised via the FDA’s 510(k) pathway. The device is listed in the FDA’s regulatory database under this clearance mechanism. The manufacturer is based in the US.
Catalogue
Smisson Stabilization System Ref K021979
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Smisson-Cartledge have in the registry?
The registry currently lists 1 device for Smisson-Cartledge. Devices recorded under merged duplicate company entries are counted once.
Which registries list Smisson-Cartledge's devices?
Among its 1 most recently registered device, Smisson-Cartledge has devices listed in FDA 510(k) (1 device).
What risk classes do Smisson-Cartledge's devices fall under?
Among its 1 most recently registered device, the classes recorded for Smisson-Cartledge's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Smisson-Cartledge in the registry?
The most recently registered devices listed for Smisson-Cartledge include SMISSON STABILIZATION SYSTEM.